- Home
- RARE vs GEL Comparison
RARE vs GEL Comparison
Compare RARE & GEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RARE | GEL |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | RARE | GEL |
|---|---|---|
| Price | $22.74 | $17.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 2 |
| Target Price | ★ $73.11 | $19.50 |
| AVG Volume (30 Days) | ★ 4.0M | 262.9K |
| Earning Date | 02-12-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 4.20% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $630,598,000.00 | ★ $2,893,959,000.00 |
| Revenue This Year | $19.68 | N/A |
| Revenue Next Year | $19.44 | $19.09 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 20.63 | ★ 42.14 |
| 52 Week Low | $18.41 | $10.28 |
| 52 Week High | $46.50 | $17.77 |
Technical Indicators
Market Signals| Indicator | RARE | GEL |
|---|---|---|
| Relative Strength Index (RSI) | 34.87 | 67.66 |
| Support Level | $22.40 | $16.14 |
| Resistance Level | $24.65 | $16.04 |
| Average True Range (ATR) | 1.53 | 0.46 |
| MACD | 0.00 | 0.16 |
| Stochastic Oscillator | 64.17 | 96.75 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About GEL Genesis Energy L.P.
Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.